Opinion
Editor’s note: The Alliance for a Stronger FDA recently offered this analysis of the Food and Drug Administration’s FY 2021 funding.
The current fiscal year (FY) 2021 Continuing Resolution runs through Dec. 11. So
Continue Reading Continuing funding for FDA complicated by congressional options